Since LRRK2 has been identified as a pathology-associated protein in PD, the reduction in the LRRK2 gene expression by DaMe in an in vitro model of PD may indicate that it may be a neuroprotective agent. This evidence concerns the gene LRRK2 and Parkinson disease.